益肾蠲痹丸通过JAK2/STAT3通路调控骨免疫微环境
本研究以体外破骨细胞单培养、调节性T细胞单培养及两者共培养体系,采用含药血清、AG490和JAK2 siRNA干预,探讨益肾蠲痹丸是否通过JAK/STAT通路调控骨免疫微环境。结果显示益肾蠲痹丸减少TRAP+细胞数及骨吸收面积,抑制RANK、NFATc1、c-fos、JAK2、STAT3表达,并促进Treg分泌IL-10、抑制JAK2和STAT3表达;抑制JAK2可改善Treg免疫抑制功能并抑制破骨细胞分化和骨吸收。结论提示益肾蠲痹丸可通过JAK2/STAT3通路调控破骨细胞介导的骨吸收和Treg介导的骨免疫。
要点
- 益肾蠲痹丸含药血清可减少TRAP+细胞数和骨吸收面积。
- 益肾蠲痹丸抑制破骨细胞RANK、NFATc1、c-fos及JAK2、STAT3表达。
- 益肾蠲痹丸促进Treg分泌IL-10并抑制JAK2/STAT3,调控骨免疫。
核心结论
- 益肾蠲痹丸可通过JAK2/STAT3信号通路调控破骨细胞介导的骨吸收和Treg介导的骨免疫,为中药调控RA骨免疫微环境提供新策略。
研究设计与样本
- 体外研究,采用破骨细胞单培养、Treg单培养及破骨细胞-Treg共培养体系,以含药血清、AG490和JAK2 siRNA进行干预。
主要发现
- 在破骨细胞单培养和共培养体系中,益肾蠲痹丸减少TRAP+细胞数和骨吸收面积,抑制RANK、NFATc1、c-fos、JAK2和STAT3表达。
- 共培养体系中Treg进一步减少TRAP+细胞数和骨吸收面积。
- 益肾蠲痹丸促进Treg分泌IL-10,同时抑制Treg中JAK2和STAT3表达。
- 用AG490和JAK2 siRNA抑制JAK2表达可改善Treg免疫抑制功能,抑制破骨细胞分化和骨吸收。
临床怎么用
- 提示益肾蠲痹丸可能通过JAK2/STAT3通路调节RA骨免疫微环境,为临床用于RA骨侵蚀防治提供体外依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) is characterized by an impaired articular bone immune microenvironment, which is associated with regulatory T cells (Tregs) hypofunction and osteoclasts (OCs) hyperfunction and leads to articular bone erosion and systemic bone loss. Studies have shown that Tregs slow bone loss in RA by regulating the bone resorption function of OCs and the JAK/STAT signaling pathway can regulate the immunosuppressive function of Tregs and reduce the bone erosion function of OCs. Yi Shen Juan Bi Pill (YSJB) is a classic Chinese herbal compound for the treatment of RA. However, whether YSJB regulates bone immune microenvironment homeostasis through JAK/STAT signaling pathway remains unclear. Based on in vitro OC single culture, Treg single culture and OC-Treg coculture systems, treatments were performed using drug-containing serum, AG490 and JAK2 siRNA to explore whether YSJB-containing serum regulates the homeostasis of the bone immune microenvironment through the JAK/STAT signaling pathway. In vitro, YSJB treatment decreased the number of TRAP+ cells and the areas of bone resorption and inhibited the expression of RANK, NFATc1, c-fos, JAK2, and STAT3 in both the OC single culture system and the OC-Treg coculture system. Tregs further reduced the number of TRAP+ cells and the areas of bone resorption in the coculture system. YSJB promoted the secretion of IL-10 while inhibiting the expression of JAK2 and STAT3 in Tregs. Moreover, inhibiting the expression of JAK2 with the JAK2 inhibitor AG490 and JAK2 siRNA improved the immunosuppressive functions of Treg, inhibited OC differentiation and bone resorption. Our study demonstrates that YSJB can regulate OC-mediated bone resorption and Treg-mediated bone immunity through the JAK2/STAT3 signaling pathway. This study provides a new strategy for regulating the bone immune microenvironment in RA with traditional Chinese medicine.
引用
- Xia Y, Fan D, Li X, et al. Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro. Front Pharmacol. 2021. PMID: 34970139. doi:10.3389/fphar.2021.746786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。